BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10619504)

  • 21. Extrapleural pneumonectomy, chemotherapy, and radiotherapy in the treatment of diffuse malignant pleural mesothelioma.
    Sugarbaker DJ; Heher EC; Lee TH; Couper G; Mentzer S; Corson JM; Collins JJ; Shemin R; Pugatch R; Weissman L
    J Thorac Cardiovasc Surg; 1991 Jul; 102(1):10-4; discussion 14-5. PubMed ID: 2072707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of tomotherapy in malignant pleural mesothelioma: first clinical results].
    Giraud P; Sylvestre A; Lisbona A; Zefkili S; Bonnette P; Le Pimpec Barthes F; Michaud JL; Perigaud C; Mahé MA
    Rev Mal Respir; 2011 May; 28(5):609-17. PubMed ID: 21645831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New therapeutic options for mesothelioma.
    Goudar RK
    Curr Oncol Rep; 2005 Jul; 7(4):260-5. PubMed ID: 15946584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pleurectomy/decortication plus chemotherapy: outcomes of 40 cases of malignant pleural mesothelioma.
    Colaut F; Toniolo L; Vicario G; Scapinello A; Visentin C; Manente P; Sartori CA
    Chir Ital; 2004; 56(6):781-6. PubMed ID: 15771030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesothelioma and radical multimodality therapy: who benefits?
    Sugarbaker DJ; Jaklitsch MT; Liptay MJ
    Chest; 1995 Jun; 107(6 Suppl):345S-350S. PubMed ID: 7781416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pemetrexed plus carboplatin or cisplatin as neoadjuvant treatment of operable malignant pleural mesothelioma (MPM).
    Pasello G; Marulli G; Polo V; Breda C; Bonanno L; Loreggian L; Rea F; Favaretto A
    Anticancer Res; 2012 Dec; 32(12):5393-9. PubMed ID: 23225442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.
    Tilleman TR; Richards WG; Zellos L; Johnson BE; Jaklitsch MT; Mueller J; Yeap BY; Mujoomdar AA; Ducko CT; Bueno R; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):405-11. PubMed ID: 19619785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical treatment of mesothelioma: anything new?
    Takigawa N; Kiura K; Kishimoto T
    Curr Oncol Rep; 2011 Aug; 13(4):265-71. PubMed ID: 21503595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multimodal therapy for malignant pleural mesothelioma including extrapleural pneumonectomy].
    Sienel W; Kirschbaum A; Passlick B
    Zentralbl Chir; 2008 Jun; 133(3):231-7. PubMed ID: 18563687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current trends in the management of malignant pleural mesothelioma.
    Tsiouris A; Gourgoulianis KI; Walesby RK
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):831-3. PubMed ID: 16761925
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.
    Sugarbaker DJ; Gill RR; Yeap BY; Wolf AS; DaSilva MC; Baldini EH; Bueno R; Richards WG
    J Thorac Cardiovasc Surg; 2013 Apr; 145(4):955-963. PubMed ID: 23434448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
    Rusch VW; Niedzwiecki D; Tao Y; Menendez-Botet C; Dnistrian A; Kelsen D; Saltz L; Markman M
    J Clin Oncol; 1992 Jun; 10(6):1001-6. PubMed ID: 1588364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete response and long-term survival in malignant pleural mesothelioma: case report.
    Takanen S; Resuli B; Graziano V; Parisi A; Lisi R; Raffetto N; Tombolini V
    Anticancer Res; 2012 Apr; 32(4):1485-7. PubMed ID: 22493390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma.
    de Bree E; van Ruth S; Baas P; Rutgers EJ; van Zandwijk N; Witkamp AJ; Zoetmulder FA
    Chest; 2002 Feb; 121(2):480-7. PubMed ID: 11834661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience.
    Ried M; Potzger T; Braune N; Neu R; Zausig Y; Schalke B; Diez C; Hofmann HS
    Eur J Cardiothorac Surg; 2013 Apr; 43(4):801-7. PubMed ID: 22885228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patterns of failure following surgical resection for malignant pleural mesothelioma.
    Jänne PA; Baldini EH
    Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trimodality management of malignant pleural mesothelioma.
    Maggi G; Casadio C; Cianci R; Rena O; Ruffini E
    Eur J Cardiothorac Surg; 2001 Mar; 19(3):346-50. PubMed ID: 11251277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant pleural mesothelioma: current treatments and emerging drugs.
    Belli C; Fennell D; Giovannini M; Gaudino G; Mutti L
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):423-37. PubMed ID: 19552609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The timing of chemotherapy in the management plan for medically operable early-stage malignant pleural mesothelioma.
    Shohdy K; Abdel-Rahman O
    Expert Rev Respir Med; 2019 Jun; 13(6):579-584. PubMed ID: 30977408
    [No Abstract]   [Full Text] [Related]  

  • 40. Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment.
    Opitz I; Lardinois D; Arni S; Hillinger S; Vogt P; Odermatt B; Rousson V; Weder W
    Eur J Cardiothorac Surg; 2007 May; 31(5):773-8. PubMed ID: 17350855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.